Thrombin regulation of cell function through protease-activated receptors: Implications for therapeutic intervention

被引:33
作者
Derian, CK [1 ]
Damiano, BP [1 ]
D'Andrea, MR [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
关键词
thrombin; platelets; vascular injury; inflammation; tumor microenvironment; fibroblasts; protease-activated receptor;
D O I
10.1023/A:1013900130415
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serine protease thrombin is well recognized as being pivotal to the maintenance of hemostasis under both normal and pathological conditions. Its cellular actions are mediated through a unique family of protease-activated receptors (PARs). These receptors represent a novel family of G protein-coupled receptors that undergo proteolytic cleavage of their amino terminus and subsequent autoactivation by a tethered peptide ligand. This paper reviews the consequences of PAR activation in thrombosis, vascular injury, inflammation, tissue injury, and within the tumor microenvironment.
引用
收藏
页码:56 / 64
页数:9
相关论文
共 126 条
[1]   Inhibition of thrombin attenuates stenosis after arterial injury in minipigs [J].
Abendschein, DR ;
Recchia, D ;
Meng, YY ;
Oltrona, L ;
Wickline, SA ;
Eisenberg, PR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1849-1855
[2]  
Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34
[3]   Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor [J].
Andrade-Gordon, P ;
Mayanoff, BE ;
Derian, CK ;
Zhang, HC ;
Addo, MF ;
Darrow, AL ;
Eckardt, AJ ;
Hoekstra, WJ ;
McComsey, DF ;
Oksenberg, D ;
Reynolds, EE ;
Santulli, RJ ;
Scarborough, RM ;
Smith, CE ;
White, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12257-12262
[4]  
ANTONACCIO MJ, 1993, J PHARMACOL EXP THER, V266, P125
[5]   Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model - Time course and effect of hirudin [J].
Barry, WL ;
Gimple, LW ;
Humphries, JE ;
Powers, ER ;
McCoy, KW ;
Sanders, JM ;
Owens, GK ;
Sarembock, IJ .
CIRCULATION, 1996, 94 (01) :88-93
[6]  
BEAVERS MP, 1999, ADV MED CH, V4, P245
[7]   Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide [J].
Blackhart, BD ;
Ruslim-Litrus, L ;
Lu, CC ;
Alves, VL ;
Teng, W ;
Scarborough, RM ;
Reynolds, EE ;
Oksenberg, D .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1178-1187
[8]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[9]   TRAFFICKING THROMBIN RECEPTORS - BIODIVERSITY ON THE RECEPTOR SUPERHIGHWAY [J].
BRASS, LF ;
WOOLKALIS, MJ ;
HOXIE, JA .
TRENDS IN CARDIOVASCULAR MEDICINE, 1995, 5 (04) :123-128
[10]   PLATELET AND FIBRIN DEPOSITION ON CORONARY STENTS IN MINIPIGS - EFFECT OF HIRUDIN VERSUS HEPARIN [J].
BUCHWALD, AB ;
SANDROCK, D ;
UNTERBERG, C ;
EBBECKE, M ;
NEBENDAHL, K ;
LUDERS, S ;
MUNZ, DL ;
WIEGAND, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (01) :249-254